DNS-7801 vs. Placebo in Parkinson's Disease
Phase 2
Terminated
- Conditions
- Parkinson's Disease
- Interventions
- Drug: PlaceboDrug: DNS-7801 (high dose)Drug: DNS-7801 (low-dose)
- First Posted Date
- 2017-10-11
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Dart NeuroScience, LLC
- Target Recruit Count
- 5
- Registration Number
- NCT03306329
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Long Beach, California, United States
🇺🇸Parkinsons Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
DNS-3379 vs. Placebo in Stroke Rehabilitation
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Dart NeuroScience, LLC
- Target Recruit Count
- 1
- Registration Number
- NCT03254160
- Locations
- 🇦🇺
John Hunter Hospital, New Lambton Heights, New South Wales, Australia
🇦🇺Royal North Shore Hospital, St Leonards, New South Wales, Australia
🇦🇺Sunshine Coast University Hospital, Birtinya, Queensland, Australia
HT-3951 vs. Placebo in Stroke Rehabilitation
- First Posted Date
- 2015-08-21
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Dart NeuroScience, LLC
- Target Recruit Count
- 61
- Registration Number
- NCT02530307
HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)
Phase 2
Completed
- Conditions
- Age-Associated Memory Impairment (AAMI)
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-12-17
- Last Posted Date
- 2015-12-30
- Lead Sponsor
- Dart NeuroScience, LLC
- Target Recruit Count
- 119
- Registration Number
- NCT02013310
Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder
Phase 1
Completed
- Conditions
- Healthy Volunteers (Part 1)Major Depressive Disorder (Part 2)
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-08-10
- Last Posted Date
- 2015-12-16
- Lead Sponsor
- Dart NeuroScience, LLC
- Target Recruit Count
- 26
- Registration Number
- NCT01413932
- Locations
- 🇺🇸
Clinical Site, Glendale, California, United States
Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712
- First Posted Date
- 2010-10-06
- Last Posted Date
- 2011-06-01
- Lead Sponsor
- Dart NeuroScience, LLC
- Target Recruit Count
- 3
- Registration Number
- NCT01215552
- Locations
- 🇺🇸
Brookhaven National Laboratory, Upton, New York, United States
Efficacy and Safety Study of BLX-028914 in Subjects With Allergic Rhinitis
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2013-03-13
- Lead Sponsor
- Dart NeuroScience, LLC
- Target Recruit Count
- 36
- Registration Number
- NCT00758446
- Locations
- 🇸🇪
Department of otorhinolaryngology, Lund, Sweden
© Copyright 2025. All Rights Reserved by MedPath